# The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

> **NCT05772871** · PHASE4 · RECRUITING · sponsor: **Jianhua Zhou** · enrollment: 402 (estimated)

## Conditions studied

- Nephrotic Syndrome in Children

## Interventions

- **DRUG:** Huaiqihuang granule
- **DRUG:** Prednisone
- **DRUG:** Levamisole placebo
- **DRUG:** Levamisole
- **DRUG:** Huaiqihuang Granule placebo

## Key facts

- **NCT ID:** NCT05772871
- **Lead sponsor:** Jianhua Zhou
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-26
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-10-30
- **Target enrollment:** 402 (ESTIMATED)
- **Last updated:** 2024-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05772871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05772871, "The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05772871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*